USNA compared with GCO: revenue, margins and what each company keeps, and the suppliers and customers both name

USNAUsana Health Sciences Inc

Mkt capRevenueRevenue

GCOGenesco Inc

Mkt capRevenueRevenue

Compare

USNAUsana Health Sciences Inc

GCOGenesco Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

USNA: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only USNA 7

—State Administration of Market Regulation ("SAMR")unlistedsupplier

—Australian Therapeutic Goods Administration ("TGA")unlistedsupplier

—China Food and Drug Administrationunlistedsupplier

—Islamic Foods and Nutrition Counsel of Americaunlistedsupplier

3 more · USNA chain ›

Shared 0

No shared counterparties.

Only GCO 1

LEVILevi'ssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

USNA, solidGCO, dashed

USNAUsana Health Sciences Inc

14.19▼−1.04%· post 14.19

Mkt cap$264.4MRevenue$223MQ2 FY26Revenue$925MFY25

GCOGenesco Inc

37.55▼−0.55%· post 37.55

ClosedOct 30 '26

Mkt cap$407.4MRevenue$530MQ2 FY27Revenue$2.4BFY26

Compare

ClosedOct 30 '26

USNAUsana Health Sciences Inc

GCOGenesco Inc

14.19▼−1.04%post 14.19

Price

37.55▼−0.55%post 37.55

$264.4M

Mkt cap

$407.4M

Q2 FY26$223M

Revenue

$530MQ2 FY27

FY25$925M

Revenue

$2.4BFY26

USNA14.19▼−1.04%vsGCO37.55▼−0.55%ClosedOct 30 '26